It is with great honor that we introduce Dr. Amy Brix as our newest senior pathologist with StageBio. We are honored to have her on the team and look forward to all she will accomplish!

As part of our pathologist team, Dr. Brix will support StageBio’s initiatives by:

• Serve as senior pathologist for assessment and reporting of anatomic pathology findings in accordance with protocol requirements.
• Work with internal staff to meet reporting deadlines and maintain productive collaborations with clients

“We’re thrilled for Dr. Brix to join the StageBio team. She is a well-known leader in environmental health and toxicology who has been instrumental in the establishment of diagnostic standards in rodent pathology and contributed to the development and evaluation of genetically modified mouse models. We look forward to her contributions and will continue to expand our capabilities and expertise as we grow.” – Dr. Katherine A. B. Knostman, Senior Director, General Toxicologic Pathology

StageBio is committed to our mission of improving lives through high-quality histopathology, diagnostics and research. Join us in welcoming Dr. Amy Brix as part of this mission!

The Stagebio team is growing! If you are interested in learning more about our current open positions, please visit our careers page here.

About Amy Brix, DVM, PhD, DACVP

Dr. Amy Brix joins StageBio after working for EPL, Inc. in North Carolina for over 22 years, the last 11 of which were spent on-site at the National Institute of Environmental Health Sciences, in the Division of the National Toxicology Program. Dr. Brix completed her residency at the University of Georgia, where she worked with Duke University to develop a canine model of von Gierke’s disease (glucose-6-phosphatase deficiency). She also completed her graduate studies at the University of Georgia, examining the effect of growth factors on the production of glycosaminoglycans and proteoglycans in cell culture. Following her PhD, she did a post-doctoral fellowship in comparative medicine at the University of Alabama at Birmingham, looking at several genetically modified mouse models of human disease.   She is excited to be part of the StageBio Team!

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates five GLP laboratories as well as three GLP specimen archiving facilities in the U.S., with substantial continued investment in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25+ board-certified veterinary pathologists and more than 60 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at stagebio.com